annual EBITDA:
$12.81M+$129.14M(+111.01%)Summary
- As of today (May 29, 2025), BCRX annual EBITDA is $12.81 million, with the most recent change of +$129.14 million (+111.01%) on December 31, 2024.
- During the last 3 years, BCRX annual EBITDA has risen by +$134.55 million (+110.52%).
- BCRX annual EBITDA is now at all-time high.
Performance
BCRX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$24.58M+$25.82M(+2093.76%)Summary
- As of today (May 29, 2025), BCRX quarterly EBITDA is $24.58 million, with the most recent change of +$25.82 million (+2093.76%) on March 31, 2025.
- Over the past year, BCRX quarterly EBITDA has increased by +$34.78 million (+340.96%).
- BCRX quarterly EBITDA is now at all-time high.
Performance
BCRX quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$47.59M+$34.78M(+271.59%)Summary
- As of today (May 29, 2025), BCRX TTM EBITDA is $47.59 million, with the most recent change of +$34.78 million (+271.59%) on March 31, 2025.
- Over the past year, BCRX TTM EBITDA has increased by +$149.27 million (+146.81%).
- BCRX TTM EBITDA is now at all-time high.
Performance
BCRX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
BCRX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +111.0% | +341.0% | +146.8% |
| 3 y3 years | +110.5% | +149.4% | +139.6% |
| 5 y5 years | +113.3% | +171.6% | +146.4% |
BCRX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +108.9% | at high | +149.4% | at high | +133.1% |
| 5 y | 5-year | at high | +107.6% | at high | +144.9% | at high | +125.8% |
| alltime | all time | at high | +107.6% | at high | +144.9% | at high | +125.8% |
BCRX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $24.58M(-2093.8%) | $47.59M(+271.6%) |
| Dec 2024 | $12.81M(-111.0%) | -$1.23M(-110.5%) | $12.81M(-153.1%) |
| Sep 2024 | - | $11.69M(-6.8%) | -$24.11M(-45.0%) |
| Jun 2024 | - | $12.55M(-223.0%) | -$43.86M(-56.9%) |
| Mar 2024 | - | -$10.20M(-73.3%) | -$101.68M(-12.6%) |
| Dec 2023 | -$116.33M(-19.1%) | -$38.16M(+373.8%) | -$116.33M(-5.3%) |
| Sep 2023 | - | -$8.05M(-82.2%) | -$122.79M(-6.0%) |
| Jun 2023 | - | -$45.26M(+82.1%) | -$130.57M(+9.8%) |
| Mar 2023 | - | -$24.86M(-44.3%) | -$118.95M(-17.3%) |
| Dec 2022 | -$143.85M(+18.2%) | -$44.61M(+181.7%) | -$143.85M(+50.1%) |
| Sep 2022 | - | -$15.83M(-52.9%) | -$95.82M(-23.0%) |
| Jun 2022 | - | -$33.65M(-32.4%) | -$124.44M(+3.4%) |
| Mar 2022 | - | -$49.76M(-1552.9%) | -$120.30M(-1.2%) |
| Dec 2021 | -$121.74M(-27.3%) | $3.42M(-107.7%) | -$121.74M(-32.3%) |
| Sep 2021 | - | -$44.46M(+50.7%) | -$179.87M(+1.0%) |
| Jun 2021 | - | -$29.50M(-42.4%) | -$178.12M(-3.3%) |
| Mar 2021 | - | -$51.20M(-6.4%) | -$184.12M(+10.1%) |
| Dec 2020 | -$167.56M(+74.0%) | -$54.70M(+28.1%) | -$167.25M(+49.5%) |
| Sep 2020 | - | -$42.71M(+20.3%) | -$111.90M(+8.1%) |
| Jun 2020 | - | -$35.51M(+3.4%) | -$103.56M(+1.1%) |
| Mar 2020 | - | -$34.33M(-5382.2%) | -$102.46M(+6.4%) |
| Dec 2019 | -$96.28M(+5.4%) | $650.00K(-101.9%) | -$96.28M(-20.9%) |
| Sep 2019 | - | -$34.37M(-0.1%) | -$121.75M(+6.4%) |
| Jun 2019 | - | -$34.41M(+22.2%) | -$114.44M(+19.1%) |
| Mar 2019 | - | -$28.15M(+13.4%) | -$96.09M(+5.2%) |
| Dec 2018 | -$91.31M(+61.6%) | -$24.82M(-8.3%) | -$91.31M(+9.2%) |
| Sep 2018 | - | -$27.06M(+68.5%) | -$83.62M(+20.5%) |
| Jun 2018 | - | -$16.06M(-31.3%) | -$69.38M(+2.1%) |
| Mar 2018 | - | -$23.37M(+36.4%) | -$67.94M(+20.2%) |
| Dec 2017 | -$56.51M(+17.3%) | -$17.13M(+33.7%) | -$56.51M(+35.9%) |
| Sep 2017 | - | -$12.82M(-12.3%) | -$41.58M(+7.6%) |
| Jun 2017 | - | -$14.62M(+22.4%) | -$38.66M(-0.4%) |
| Mar 2017 | - | -$11.95M(+443.0%) | -$38.81M(-19.4%) |
| Dec 2016 | -$48.17M(+28.0%) | -$2.20M(-77.8%) | -$48.17M(-23.2%) |
| Sep 2016 | - | -$9.89M(-33.1%) | -$62.73M(-5.2%) |
| Jun 2016 | - | -$14.77M(-30.7%) | -$66.18M(+46.6%) |
| Mar 2016 | - | -$21.32M(+27.2%) | -$45.15M(+20.0%) |
| Dec 2015 | -$37.64M(-5.9%) | -$16.75M(+25.6%) | -$37.64M(+20.6%) |
| Sep 2015 | - | -$13.34M(-313.2%) | -$31.20M(+23.1%) |
| Jun 2015 | - | $6.26M(-145.3%) | -$25.34M(-43.7%) |
| Mar 2015 | - | -$13.80M(+33.8%) | -$44.98M(+12.4%) |
| Dec 2014 | -$40.01M(+59.9%) | -$10.32M(+38.1%) | -$40.01M(+18.3%) |
| Sep 2014 | - | -$7.47M(-44.1%) | -$33.83M(+2.2%) |
| Jun 2014 | - | -$13.38M(+51.3%) | -$33.10M(+8.0%) |
| Mar 2014 | - | -$8.84M(+114.1%) | -$30.64M(+22.4%) |
| Dec 2013 | -$25.03M(-25.9%) | -$4.13M(-38.8%) | -$25.03M(-18.2%) |
| Sep 2013 | - | -$6.75M(-38.2%) | -$30.60M(-5.1%) |
| Jun 2013 | - | -$10.92M(+238.2%) | -$32.25M(-0.1%) |
| Mar 2013 | - | -$3.23M(-66.7%) | -$32.29M(-4.4%) |
| Dec 2012 | -$33.79M(-35.4%) | -$9.71M(+15.6%) | -$33.79M(-12.1%) |
| Sep 2012 | - | -$8.40M(-23.4%) | -$38.45M(-9.9%) |
| Jun 2012 | - | -$10.96M(+132.0%) | -$42.68M(-6.7%) |
| Mar 2012 | - | -$4.72M(-67.1%) | -$45.74M(-12.5%) |
| Dec 2011 | -$52.29M(+65.5%) | -$14.37M(+13.9%) | -$52.29M(+12.3%) |
| Sep 2011 | - | -$12.62M(-10.0%) | -$46.55M(+4.3%) |
| Jun 2011 | - | -$14.02M(+24.4%) | -$44.61M(+10.1%) |
| Mar 2011 | - | -$11.27M(+30.6%) | -$40.52M(+28.3%) |
| Dec 2010 | -$31.59M(+160.5%) | -$8.63M(-19.2%) | -$31.59M(+322.8%) |
| Sep 2010 | - | -$10.68M(+7.6%) | -$7.47M(+5.3%) |
| Jun 2010 | - | -$9.93M(+324.8%) | -$7.09M(+29.3%) |
| Mar 2010 | - | -$2.34M(-115.1%) | -$5.49M(-54.8%) |
| Dec 2009 | -$12.12M | $15.48M(-250.3%) | -$12.12M(-30.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2009 | - | -$10.30M(+23.7%) | -$17.34M(+7.0%) |
| Jun 2009 | - | -$8.33M(-7.3%) | -$16.20M(-22.4%) |
| Mar 2009 | - | -$8.98M(-187.4%) | -$20.87M(-18.3%) |
| Dec 2008 | -$25.54M(-17.4%) | $10.27M(-212.0%) | -$25.54M(-33.9%) |
| Sep 2008 | - | -$9.17M(-29.5%) | -$38.62M(-5.9%) |
| Jun 2008 | - | -$13.00M(-4.7%) | -$41.04M(+16.0%) |
| Mar 2008 | - | -$13.64M(+385.5%) | -$35.38M(+57.6%) |
| Dec 2007 | -$30.91M(-33.1%) | -$2.81M(-75.7%) | -$22.44M(-25.6%) |
| Sep 2007 | - | -$11.59M(+57.9%) | -$30.15M(-13.5%) |
| Jun 2007 | - | -$7.34M(+933.8%) | -$34.86M(-9.0%) |
| Mar 2007 | - | -$709.80K(-93.3%) | -$38.32M(-17.0%) |
| Dec 2006 | -$46.17M(+75.5%) | -$10.52M(-35.4%) | -$46.17M(+7.5%) |
| Sep 2006 | - | -$16.29M(+50.9%) | -$42.93M(+25.0%) |
| Jun 2006 | - | -$10.80M(+26.1%) | -$34.35M(+17.4%) |
| Mar 2006 | - | -$8.56M(+17.6%) | -$29.27M(+11.2%) |
| Dec 2005 | -$26.31M(+26.5%) | -$7.28M(-5.6%) | -$26.31M(+8.6%) |
| Sep 2005 | - | -$7.71M(+34.9%) | -$24.23M(+11.5%) |
| Jun 2005 | - | -$5.71M(+1.9%) | -$21.73M(+3.5%) |
| Mar 2005 | - | -$5.61M(+7.9%) | -$21.00M(+1.0%) |
| Dec 2004 | -$20.79M(+65.3%) | -$5.20M(-0.3%) | -$20.79M(+6.2%) |
| Sep 2004 | - | -$5.21M(+4.5%) | -$19.58M(+11.7%) |
| Jun 2004 | - | -$4.99M(-7.6%) | -$17.52M(+13.1%) |
| Mar 2004 | - | -$5.40M(+35.6%) | -$15.49M(+23.2%) |
| Dec 2003 | -$12.58M(-27.9%) | -$3.98M(+26.2%) | -$12.58M(-4.5%) |
| Sep 2003 | - | -$3.15M(+6.6%) | -$13.17M(+0.4%) |
| Jun 2003 | - | -$2.96M(+19.1%) | -$13.12M(-12.9%) |
| Mar 2003 | - | -$2.48M(-45.7%) | -$15.07M(-15.9%) |
| Dec 2002 | -$17.46M(+343.5%) | -$4.58M(+47.4%) | -$17.92M(+14.5%) |
| Sep 2002 | - | -$3.10M(-36.7%) | -$15.64M(+26.2%) |
| Jun 2002 | - | -$4.91M(-8.0%) | -$12.39M(+72.5%) |
| Mar 2002 | - | -$5.33M(+131.2%) | -$7.18M(+71.6%) |
| Dec 2001 | -$3.94M(-57.0%) | -$2.31M(-1678.8%) | -$4.19M(-12.3%) |
| Sep 2001 | - | $146.00K(-52.1%) | -$4.77M(-29.0%) |
| Jun 2001 | - | $305.00K(-113.1%) | -$6.72M(-27.7%) |
| Mar 2001 | - | -$2.33M(-19.4%) | -$9.29M(+0.8%) |
| Dec 2000 | -$9.16M(+20.6%) | -$2.89M(+60.8%) | -$9.22M(+6.9%) |
| Sep 2000 | - | -$1.80M(-20.5%) | -$8.62M(-7.5%) |
| Jun 2000 | - | -$2.27M(+0.4%) | -$9.32M(+26.6%) |
| Mar 2000 | - | -$2.26M(-1.9%) | -$7.36M(-1.9%) |
| Dec 1999 | -$7.60M(+38.2%) | -$2.30M(-8.0%) | -$7.51M(+8.7%) |
| Sep 1999 | - | -$2.50M(+711.4%) | -$6.91M(+262.0%) |
| Jun 1999 | - | -$308.00K(-87.2%) | -$1.91M(-57.6%) |
| Mar 1999 | - | -$2.40M(+41.2%) | -$4.50M(-13.5%) |
| Dec 1998 | -$5.50M(-53.0%) | -$1.70M(-168.0%) | -$5.20M(-23.5%) |
| Sep 1998 | - | $2.50M(-186.2%) | -$6.80M(-42.9%) |
| Jun 1998 | - | -$2.90M(-6.5%) | -$11.90M(+5.3%) |
| Mar 1998 | - | -$3.10M(-6.1%) | -$11.30M(-2.6%) |
| Dec 1997 | -$11.70M(+42.7%) | -$3.30M(+26.9%) | -$11.60M(+1.8%) |
| Sep 1997 | - | -$2.60M(+13.0%) | -$11.40M(+2.7%) |
| Jun 1997 | - | -$2.30M(-32.4%) | -$11.10M(+12.1%) |
| Mar 1997 | - | -$3.40M(+9.7%) | -$9.90M(+19.3%) |
| Dec 1996 | -$8.20M(-3.5%) | -$3.10M(+34.8%) | -$8.30M(+13.7%) |
| Sep 1996 | - | -$2.30M(+109.1%) | -$7.30M(+4.3%) |
| Jun 1996 | - | -$1.10M(-38.9%) | -$7.00M(-6.7%) |
| Mar 1996 | - | -$1.80M(-14.3%) | -$7.50M(-10.7%) |
| Dec 1995 | -$8.50M(+37.1%) | -$2.10M(+5.0%) | -$8.40M(+3.7%) |
| Sep 1995 | - | -$2.00M(+25.0%) | -$8.10M(+6.6%) |
| Jun 1995 | - | -$1.60M(-40.7%) | -$7.60M(-1.3%) |
| Mar 1995 | - | -$2.70M(+50.0%) | -$7.70M(+22.2%) |
| Dec 1994 | -$6.20M | -$1.80M(+20.0%) | -$6.30M(+40.0%) |
| Sep 1994 | - | -$1.50M(-11.8%) | -$4.50M(+50.0%) |
| Jun 1994 | - | -$1.70M(+30.8%) | -$3.00M(+130.8%) |
| Mar 1994 | - | -$1.30M | -$1.30M |
FAQ
- What is BioCryst Pharmaceuticals annual EBITDA?
- What is the all time high annual EBITDA for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals annual EBITDA year-on-year change?
- What is BioCryst Pharmaceuticals quarterly EBITDA?
- What is the all time high quarterly EBITDA for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals quarterly EBITDA year-on-year change?
- What is BioCryst Pharmaceuticals TTM EBITDA?
- What is the all time high TTM EBITDA for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals TTM EBITDA year-on-year change?
What is BioCryst Pharmaceuticals annual EBITDA?
The current annual EBITDA of BCRX is $12.81M
What is the all time high annual EBITDA for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high annual EBITDA is $12.81M
What is BioCryst Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, BCRX annual EBITDA has changed by +$129.14M (+111.01%)
What is BioCryst Pharmaceuticals quarterly EBITDA?
The current quarterly EBITDA of BCRX is $24.58M
What is the all time high quarterly EBITDA for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high quarterly EBITDA is $24.58M
What is BioCryst Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, BCRX quarterly EBITDA has changed by +$34.78M (+340.96%)
What is BioCryst Pharmaceuticals TTM EBITDA?
The current TTM EBITDA of BCRX is $47.59M
What is the all time high TTM EBITDA for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high TTM EBITDA is $47.59M
What is BioCryst Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, BCRX TTM EBITDA has changed by +$149.27M (+146.81%)